Array BioPharma Inc (NASDAQ:ARRY) - Share price - Overview


Stock Report

Array BioPharma Inc ARRY

Last Price
$22.49

Day Change
-1.50|-6.25%

As of 22/03/2019
19:58:26 EDT | USD
Minimum 15 Minutes Delay.

Last Close23.99
Day Range22.47 - 23.95
Mkt Cap4.91Bil
52-Wk Range12.56 - 24.76
Yield %-
ISINUS04269X1054
Volume3,061,214
P/E-42.43
P/S19.76
P/CF-51.21

Share Price

Financials
201620172018
More ...
Income Statement
Revenue137.88150.85173.77
Operating Income-82.21-102.08-129.93
Net Income-92.84-116.82-147.35
Basic EPS-0.65-0.72-0.74
Avg. Diluted Shares Outstanding143163198
Balance Sheet
Current Assets155.30270.18451.54
Non Current Assets13.608.978.82
Total Assets168.90279.15460.36
Current Liabilities52.4369.5595.93
Total Liabilities206.83267.42240.62
Total Equity-37.9311.73219.74
Cash Flow
Operating Cash Flow-70.09-39.35-119.78
Capital Expenditure-3.16-3.52-1.23
Free Cash Flow-73.25-42.87-121.02

In millions, except "Basic EPS". Currency is USD.

Company Profile

Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

June

Employees

298
Key Stats
More ...
Price/Earning TTM-45.26
Price/Book18.35
Price/Sales TTM21.07
Rev Growth (3 year avg)49.59
EPS Growth (3 year avg)-
Operating Margin % TTM-74.77
Net Margin % TTM-84.79
ROE TTM-127.31
Debt/Equity0.42
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.